Showing results (771-780 of 1,272) with videos related to

Sort By:
Pageof 128
Journal of Endourology|December 23, 1999
Guaifenesin- and ephedrine-induced stonesD G Assimos, P Langenstroer, R F Leinbach, et al.
Mbio|April 19, 2012
The NorR regulon is critical for Vibrio cholerae resistance to nitric oxide and sustained colonization of the intestinesAndrew M Stern, Amanda J Hay, Zhi Liu, et al.
Presse Medicale (Paris, France : 1983)|June 17, 1989
[Continuous high-dose corticosteroid pressured aerosol therapy in steroid-dependent asthma]P Even, I Caubarrère, H Sors, et al.
Archives of Neurology|September 1, 1991
The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patientsM Stern, E Dulaney, S B Gruber, et al.
Scandinavian Journal of Gastroenterology|April 1, 1997
Plasma concentrations of cholecystokinin and neurotensin in patients with cystic fibrosisK H Herzig, J Domagk, R Nustede, et al.
Pathologie-Biologie|May 1, 1984
[Bronchial diffusion of new anti-pseudomonal beta-lactams. Clinical significance]E Bergogne-Berezin, J Pierre, G Berthelot, et al.
The Journal of Clinical Investigation|July 4, 2001
Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transportK Ozawa, T Kondo, O Hori, et al.
Biochemistry|January 9, 1990
Glycinamide ribonucleotide synthetase from Escherichia coli: cloning, overproduction, sequencing, isolation, and characterizationY S Cheng, Y Shen, J Rudolph, et al.
Physical Review Letters|March 10, 2012
NMR probing of the spin polarization of the ν=5/2 quantum Hall stateM Stern, B A Piot, Y Vardi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 1993
Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five yearsA J Hughes, S Bishop, B Kleedorfer, et al.
Pageof 128